T

TRIMTECH Therapeutics

HealthNeurodegenerative Diseases📍 Cambridge, United Kingdom

TRIMTECH Therapeutics is focused on developing innovative treatments for neurodegenerative diseases. The company aims to address significant unmet medical needs in this area, making it a notable player in the health sector. The recent funding round will support their research and development efforts.

Total raised
$44.1M
tracked to date
Latest round
Seed
Jun 23, 2026

Is this your company?

Claim this profile to get matched with investors who fund Health startups in United Kingdom.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 UK Funding Report

Read the Q2 2026 UK report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-uk-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 UK Funding Report</a>

Funding history

  1. 1
    $44.1MSeedJun 23, 2026
    Announcement ↗

TRIMTECH Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile